4D Molecular Therapeutics CEO Sells Over $298K in Company Stock
In a recent disclosure filing, 4D Molecular Therapeutics (NASDAQ: FDMT) reported that its Chief Executive Officer, David Kirn, sold company …
Tag: David Kirn sells stocks